Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 347

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

Open access
Marra, Christina M, Zhao, Yu, Clifford, David B, Letendre, Scott, Evans, Scott, Henry, Katherine, Ellis, Ronald J, Rodriguez, Benigno, Coombs, Robert W, Schifitto, Giovanni, McArthur, Justin C, Robertson, Kevin·2009·AIDS

Abstract

OBJECTIVE: To determine whether antiretroviral regimens with good central nervous system (CNS) penetration control HIV in cerebrospinal fluid (CSF) and improve cognition. DESIGN: Multisite longitudinal observational study. SETTING: Research clinics. STUDY PARTICIPANTS: One hundred and one individuals with advanced HIV beginning or changing a new potent antiretroviral regimen were enrolled in the study. Data for 79 participants were analyzed. Participants underwent structured history and neurological examination, venipuncture, lumbar puncture, and neuropsychological tests at entry, 24, and 52 weeks. INTERVENTION: Antiretroviral regimens were categorized as CNS penetration effectiveness (CPE) rank of at least 2 or less than 2. Generalized estimating equations were used to examine associations over the course of the study. MAIN OUTCOME MEASURES: Concentration of HIV RNA in CSF and blood and neuropsychological test scores (NPZ4 and NPZ8). RESULTS: Odds of suppression of CSF HIV RNA were higher when CPE rank was at least 2 than when it was less than 2. Odds of suppression of plasma HIV RNA were not associated with CPE rank. Among participants with impaired neuropsychological performance at entry, those prescribed regimens with a CPE rank of at least 2 or more antiretrovirals had lower composite NPZ4 scores over the course of the study. CONCLUSION: Antiretroviral regimens with good CNS penetration, as assessed by CPE rank, are more effective in controlling CSF (and presumably CNS) viral replication than regimens with poorer penetration. In this study, antiretrovirals with good CNS penetration were associated with poorer neurocognitive performance. A larger controlled trial is required before any conclusions regarding the influence of specific antiretrovirals on neurocognitive performance should be made.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qad.0b013e32832c4152

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 347

Metadata

Authors
Marra, C. M., Zhao, Y., Clifford, D. B., Letendre, S., Evans, S., Henry, K., Ellis, R. J., Rodriguez, B., Coombs, R. W., Schifitto, G., McArthur, J. C., & Robertson, K.
Venue
AIDS
Published
2009-07-17
Volume
23
Issue
11
Pages
1359-1366
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2093635022
Cited by
347
References
17
FWCI
22.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. https://app.cochat.ai/papers/10.1097/qad.0b013e32832c4152
The paper
Marra, C. M., Zhao, Y., Clifford, D. B., Letendre, S., Evans, S., Henry, K., Ellis, R. J., Rodriguez, B., Coombs, R. W., Schifitto, G., McArthur, J. C., & Robertson, K. (2009). Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. https://doi.org/10.1097/qad.0b013e32832c4152

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.